ICU Medical, Inc. (NASDAQ:ICUI) Shares Sold by Daiwa Securities Group Inc.

Daiwa Securities Group Inc. decreased its holdings in shares of ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 85.2% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,659 shares of the medical instruments supplier's stock after selling 15,283 shares during the quarter. Daiwa Securities Group Inc.'s holdings in ICU Medical were worth $413,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also made changes to their positions in the company. FMR LLC increased its stake in ICU Medical by 2,676.6% during the 3rd quarter. FMR LLC now owns 104,094 shares of the medical instruments supplier's stock worth $18,968,000 after buying an additional 100,345 shares during the period. State Street Corp increased its stake in ICU Medical by 9.3% during the 3rd quarter. State Street Corp now owns 907,607 shares of the medical instruments supplier's stock worth $165,384,000 after buying an additional 77,506 shares during the period. Raymond James Financial Inc. purchased a new stake in ICU Medical during the 4th quarter worth $10,003,000. Geode Capital Management LLC increased its stake in ICU Medical by 9.6% during the 3rd quarter. Geode Capital Management LLC now owns 546,954 shares of the medical instruments supplier's stock worth $99,687,000 after buying an additional 48,106 shares during the period. Finally, Proficio Capital Partners LLC purchased a new stake in ICU Medical during the 4th quarter worth $5,779,000. Institutional investors and hedge funds own 96.10% of the company's stock.

ICU Medical Stock Down 2.1 %

Shares of ICUI traded down $3.16 during midday trading on Thursday, hitting $148.09. The company had a trading volume of 218,470 shares, compared to its average volume of 255,690. ICU Medical, Inc. has a 52 week low of $93.36 and a 52 week high of $196.26. The company's 50 day moving average price is $156.48 and its 200 day moving average price is $164.65. The company has a quick ratio of 1.03, a current ratio of 2.29 and a debt-to-equity ratio of 0.75. The stock has a market cap of $3.63 billion, a price-to-earnings ratio of -32.40 and a beta of 0.73.

Remove Ads

Wall Street Analysts Forecast Growth

Several research firms recently issued reports on ICUI. StockNews.com raised shares of ICU Medical from a "hold" rating to a "buy" rating in a research note on Tuesday. Raymond James set a $97.00 target price on shares of ICU Medical in a research report on Wednesday, March 12th. Finally, Jefferies Financial Group raised shares of ICU Medical from a "hold" rating to a "buy" rating and set a $200.00 target price for the company in a research report on Wednesday, December 11th. One equities research analyst has rated the stock with a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat, the company has an average rating of "Buy" and an average price target of $168.67.

Insider Activity

In other news, CEO Vivek Jain sold 1,373 shares of ICU Medical stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $155.48, for a total value of $213,474.04. Following the completion of the transaction, the chief executive officer now directly owns 104,593 shares of the company's stock, valued at approximately $16,262,119.64. The trade was a 1.30 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Company insiders own 6.70% of the company's stock.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.